Ophthotech Corp (OPHT) Covered Calls

Ophthotech Corp covered calls Ophthotech Corp is engaged in the development of novel therapeutics applied in the treatment of ophthalmological diseases. Its product candidate, Fovista, is applied in the treatment of wet age-related macular degeneration.

You can sell covered calls on Ophthotech Corp to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for OPHT (prices last updated Fri 4:16 PM ET):

Ophthotech Corp (OPHT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.38 -0.03 1.36 1.43 226K - 0.0B
Covered Calls For Ophthotech Corp (OPHT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 2.5 0.00 1.43 0.0% 0.0%
Jan 18 2.5 0.00 1.43 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Ophthotech Corp. operates as a biopharmaceutical company. It focuses on discovering, developing and commercializing novel therapeutics to treat diseases of the eye. The company develops therapies for age-related macular degeneration. Its product candidates include Fovista Anti platelet derived growth factor Therapy, Zimura Anti-Complement and Aptamer Technology. The company was founded on January 5, 2007 by David R. Guyer and Samir Chandrakant Patel and is headquartered in New York, NY.